Keep going to the next opportunity! - Clinical Project Coordinator Baxter Employee Review

Their clinical trial pipeline is a bust. They run Phase 3 clinical trials on very anecdotal information that cost extraordinary amounts of money to conduct and fail to meet primary and secondary endpoints or run trials too difficult to recruit. They outsource things with too little management oversight so when it falls apart, it is the fault of the CRO and never of Baxter. Huge amounts of time are spent on busy work and the SOPs that govern the work are 25 or more pages long and internally inconsistent or so vague nobody knows what they mean. Each process requires many steps including finding the person who actually knows how to do it so they can help you to get it done. The inefficiencies are legendary and people laugh about the SOPs or that a particular clinical trial is mess. Yet, nobody ever asks why that trial was a mess or does any "lessons learned." The presentations regardless of topic are notoriously poor with each containing grammar and spelling mistakes or are in need of updating to cover the new name for the group or the department. Everything gets second guessed no matter how small the issue so nobody is empowered and the usual decision is not to decide or run to maintain the status quo.